Sisram Medical Ltd SRAMF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.44
- Day Range
- $0.06–0.06
- 52-Week Range
- $0.06–0.98
- Bid/Ask
- $0.05 / $0.46
- Shares Outstanding
- 468.34M
- Market Cap
- $25.85M
- Volume/Avg
- 1,900 / 1,137
Key Statistics
- Price/Earnings (Normalized)
- 1.68
- Price/Sales
- 0.07
- Dividend Yield (Trailing)
- 21.95%
- Dividend Yield (Forward)
- 21.95%
- Dividend Payment Schedule
- Sep
- Total Yield
- 21.95%
Company Profile
Sisram Medical Ltd is an investment holding company specializing in medical technology for healthcare. The Company is involved in research, development, design, manufacture, sale and marketing of medical aesthetics and dental equipment, home use devices, injectables and cosmeceuticals products. The company's products include Soprano Titanium, Colibri technology, and others. Some of the company's brands are Alma, Soprano, Copulla, and LMNT. It operates through the following geographical segments: North America which is its key revenue generating market, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 1,043
- Website
- https://www.sisram-medical.com
Valuation
|
Metric
|
SRAMF
|
|---|---|
Price/Earnings (Normalized) | 1.68 |
Price/Book Value | 0.05 |
Price/Sales | 0.07 |
Price/Cash Flow | — |
Price/Earnings
SRAMF
Financial Strength
|
Metric
|
SRAMF
|
|---|---|
Quick Ratio | 1.60 |
Current Ratio | 2.37 |
Interest Coverage | 5.77 |
Quick Ratio
SRAMF
Profitability
|
Metric
|
SRAMF
|
|---|---|
Return on Assets (Normalized) | 3.67% |
Return on Equity (Normalized) | 5.12% |
Return on Invested Capital (Normalized) | 4.84% |
Return on Assets
SRAMF
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|C%#?^T | LOCK|?NXg | $176B | |||
| Medtronic PLC
MDT
| LOCK|Gh^Nhs | LOCK|gbgn | $118B | |||
| Stryker Corp
SYK
| LOCK|<z&bRVL | LOCK|TC | $108B | |||
| Boston Scientific Corp
BSX
| LOCK|?XH!%> | LOCK|SHmD@ | $64B | |||
| Edwards Lifesciences Corp
EW
| LOCK|B<f$^JX# | LOCK|Wdjz^ | $50B | |||
| DexCom Inc
DXCM
| LOCK|$q?%##B | LOCK|Q@Xc> | $32B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|DgQ@&#t | LOCK|H#@ | $31B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|$Q | LOCK|^lb | $24B | |||
| Steris PLC
STE
| LOCK|<tv^#&l | LOCK|%!V% | $21B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|cgW>nQF | LOCK|?! | $18B |
United States